Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Greenwich LifeSciences, Inc. (GLSI) had Free Cash Flow per Share of $-0.56 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-15.79M |
|
-- |
|
-- |
|
$16.01M |
|
$-16.01M |
|
$0.22M |
|
$-15.79M |
|
$-15.79M |
|
$-15.79M |
|
$-15.79M |
|
$-15.79M |
|
$-15.79M |
|
$-16.01M |
|
$-16.01M |
|
13.02M |
|
13.02M |
|
$-1.21 |
|
$-1.21 |
|
| Balance Sheet Financials | |
$4.09M |
|
-- |
|
$0.00M |
|
$4.09M |
|
$1.56M |
|
-- |
|
-- |
|
$1.56M |
|
$2.53M |
|
$2.53M |
|
$2.53M |
|
13.15M |
|
| Cash Flow Statement Financials | |
$-7.27M |
|
-- |
|
$4.37M |
|
$6.99M |
|
$4.09M |
|
$-2.90M |
|
$7.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-623.07% |
|
-623.51% |
|
-385.68% |
|
-623.07% |
|
$0.19 |
|
|
Free Cash Flow per Share |
$-0.56 |
$-0.56 |
|